Company Profile
Updated: 17-SEP-09Genzyme Diagnostics
Exporter
6659 Top Gun St., San Diego, CA 92121-4113, United States
(800)781-9384, (858)452-3198, (858)452-3258 fax, http://www.genzyme.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research and development. Manufature: laboratory, biotechnology, and diagnostic healthcare products.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
This Global Outlook Series on Genetic Engineering Provides a Collection of Market Briefs and Concise Summaries of Research Findings.
Gene Therapy Weekly; 11/19/2009; 1522 words; ...MerLion Pharmaceuticals MTS Health Investors Acquires DNA Diagnostic Center Bayer HealthCare Takes Over Direvo Biotech QIAGEN Completes...Eureka, Glycos Partner to Develop Bacterium for Biorefinery Genzyme Acquires Rights to MabCampath, Fludara and Leukine Quantel...
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series a Funding for the Development of Technologies to Personalize Cancer Therapy.
Cancer Weekly; 11/17/2009; 1048 words; ...ity is developing diagnostics to determine optimal...leader in the fields of diagnostics, oncology and personalized...Formerly president of Genzyme Genetics, she expanded...nation's largest diagnostic laboratories. She...ability to bring new diagnostics to market. We are...Drug Development, ...
WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board.
Cancer Weekly; 11/17/2009; 830 words; ...commercializing novel molecular diagnostics for cancer detection...institutions (see also Diagnostics). "We are very...successes developing diagnostic products coupled with...development of molecular diagnostic platforms for cancer...companies including: Genzyme Genetics, Myriad...Cancer ...
Genzyme Issues Letters to U.S. Healthcare Providers.(Letter to the editor)
Business Wire; 11/13/2009; 895 words; ...approximately 100 countries, Genzyme is a leader in the effort to...transplant and immune disease, and diagnostic testing. Genzyme's commitment to innovation...areas of unmet medical need. Genzyme[R], Cerezyme[R], Fabrazyme...
Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA.
PR Newswire; 11/11/2009; 1017 words; ...approximately 100 countries, Genzyme is a leader in the effort to...transplant and immune disease, and diagnostic testing. Genzyme's commitment to innovation...areas of unmet medical need. Genzyme's press releases and other...
Recent News Articles
- Genzyme Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Lung Cancer Diagnostic.
PR Newswire - January 15, 2008 - Genzyme Launches New Diagnostic Test for Common Blood Cancer and Genentech Announces Vice President and Officer Appointments in Product Development and Finance.
M2 Presswire - July 28, 2006 - Genzyme Launches New Diagnostic Test for Common Blood Cancer.
PR Newswire - July 27, 2006 - Competitive Technologies, Inc. Licenses Homocysteine Assay to Genzyme; Genzyme's Equal Diagnostic Homocysteine Assays Carry Pass-Through License to Customers.(Company Profile)
Business Wire - December 21, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning